Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-25-005606
Filing Date
2025-05-14
Accepted
2025-05-14 16:20:57
Documents
58
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cvm_10q.htm   iXBRL 10-Q 687510
2 CERTIFICATION cvm_ex31.htm EX-31 22481
3 CERTIFICATION cvm_ex32.htm EX-32 5114
9 cvm_10qimg14.jpg GRAPHIC 35445
10 cvm_10qimg9.jpg GRAPHIC 21073
11 cvm_10qimg8.jpg GRAPHIC 20937
12 cvm_10qimg10.jpg GRAPHIC 19867
13 cvm_10qimg11.jpg GRAPHIC 30503
14 cvm_10qimg12.jpg GRAPHIC 31977
15 cvm_10qimg13.jpg GRAPHIC 24211
  Complete submission text file 0001654954-25-005606.txt   3848922

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cvm-20250331.xsd EX-101.SCH 35122
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20250331_lab.xml EX-101.LAB 227211
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20250331_cal.xml EX-101.CAL 37020
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20250331_pre.xml EX-101.PRE 179698
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20250331_def.xml EX-101.DEF 80618
61 EXTRACTED XBRL INSTANCE DOCUMENT cvm_10q_htm.xml XML 438892
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 25946018
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)